The Vision Thief

DEC. 15, 2017
Glaucoma is the leading cause of irreversible blindness throughout the world. Read about the Lasker/IRRF initiative aiming to accelerate discovery of novel ways to treat and prevent this condition.

Astrocytes and Glaucoma

MAY 23, 2017
The IRRF initiative has produced five review articles published in a special issue of Experimental Eye Research discussing the big questions in the Glaucoma field and identifying topics and experiments that should be addressed within the next five years.

Amblyopia: Challenges and Opportunities

APRIL 20, 2017
The fourth report from the Albert & Mary Lasker Foundation and the International Retinal Research Foundation's collaboration provides new insights and innovative approaches to better diagnose, treat, and prevent amblyopia.

Restoring Vision to the Blind

JAN. 7, 2015
The third report from the Albert and Mary Lasker Foundation and the International Retinal Research Foundation's 10-year collaboration, recently published in the ARVO journal Translational Vision Science & Technology (TVST), explores which approaches to restoring sight are most promising and most likely to benefit the greatest number of blind individuals who have lost vision as a result of retinal degenerative disease.

Diabetic Retinopathy: A Path to Progress

MARCH 24, 2012
The Lasker/IRRF Initiative's second report, released in 2012, addresses diabetic retinopathy, the most common and most serious of the ocular complications of diabetes mellitus.

Astrocytes and Glaucomatous Neurodegeneration

OCT. 14, 2010
The first program of the Lasker/International Retinal Research Foundation's Initiative for Innovation in Vision Science, launched in 2009, explored the dual role of astrocytes in glaucoma.

Go to Top